Amylyx Pharmaceuticals’ stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.81%), Point72 Asset Management L.P. (4.07%), Stonepine Capital Management LLC (3.70%), Perceptive Advisors LLC (2.76%), Franklin Resources Inc. (1.96%) and Goldman Sachs Group Inc. (1.86%). Insiders that own company stock include George M Milne Jr, Gina Mazzariello, Global Investors Lp Viking, James M Frates, Joshua B Cohen, Justin B Klee, Morningside Venture Investment and Patrick D Yeramian.
View institutional ownership trends.
Amylyx Pharmaceuticals (AMLX) Stock Price, News & Analysis
Date:
More like thisRelated
Tampa RV giant Lazydays to delist from Nasdaq
Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...
Granite Geek: New Hampshire might get access to ‘balcony solar’
I had solar panels put on my roof six...
TSX Today: What to Watch for in Stocks on Monday, November 10
Despite firm gold and silver prices, Canadian stocks...
While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!
As market-wide fear grips the sector, the Binance Coin...